One of just nine voucher recipients chosen and the only one in the eye space, the selection spotlights Dompé’s dedication to accelerate innovation and deliver breakthrough therapies to patients who ...

The FDA has issued a supplemental biologics license application to teclistamab, a Johnson & Johnson therapy, to participate in its National Priority Voucher pilot program, according to Dec. 15 news ...

The FDA has approved Augmentin XR, an oral antibacterial, under its Commissioner’s National Priority Voucher pilot program, marking the first approval granted through the expedited review pathway. The ...

Less than two weeks into his new role as Auburn's head football coach, Alex Golesh has a tremendous task ahead of him. AUBURN, Ala.-- A little over ten days into his tenure on the plains, new Auburn ...

The U.S. House of Representatives has given a unanimous thumbs-up to the Give Kids A Chance Act, which would revive the FDA’s rare pediatric review voucher program following its expiration in December ...

As the FDA's Commissioner's National Priority Voucher (CNPV) program has picked up steam, with 15 companies now having secured ultrafast drug reviews, questions and criticisms about the initiative ...

Two members of Congress launched an investigation into FDA Commissioner Marty Makary, MD, MPH, and his use of "priority vouchers" for expedited drug approvals, suggesting that the voucher program ...

As someone who grew up playing online multiplayer games, I'm no stranger to toxicity. From League of Legends to Overwatch 2, I've been told get back in the kitchen many a time, and while it doesn't ...

Michigan’s new LEADS pilot aims to help employers reduce stress, burnout and communication-related risks by integrating mental health into core occupational health and safety practices. A new Michigan ...

President Trump and FIFA President Gianni Infantino on Monday announced expedited visa processing for individuals attending next year’s FIFA World Cup in the U.S. Speaking in the Oval Office next to ...

Two obesity drugs are among the six new medications that could get faster FDA review under a new pilot program open to products addressing certain national health priorities. Rare and infectious ...